Jennifer L Guerriero
Overview
Explore the profile of Jennifer L Guerriero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
2665
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stawiski K, Perera-Bel J, Rodriguez-Vida A, Juanpere Rodero N, Lee J, Michaud D, et al.
bioRxiv
. 2025 Mar;
PMID: 40060517
Platinum-based chemotherapy combined with immunotherapy provides durable disease control in advanced urothelial cancer. However, cisplatin and carboplatin differently impact the tumor immune microenvironment, affecting chemo-immunotherapy response. Here, we evaluate immune...
2.
Miller T, El Farran C, Couturier C, Chen Z, DAntonio J, Verga J, et al.
Nature
. 2025 Feb;
PMID: 40011771
Gliomas are incurable malignancies notable for having an immunosuppressive microenvironment with abundant myeloid cells, the immunomodulatory phenotypes of which remain poorly defined. Here we systematically investigate these phenotypes by integrating...
3.
Shimada K, Michaud D, Cui Y, Zheng K, Goldberg J, Ju Z, et al.
bioRxiv
. 2024 Dec;
PMID: 39651157
Statement Of Significance: This study elucidates the immunosuppressive role of ER signaling in breast cancer, highlighting a complex interplay between cancer, stromal, and immune cells and reveals potential approaches to...
4.
Aird K, Chaudhuri A, Guerriero J, Gur-Cohen S, Izar B, Jenkins B, et al.
Cancer Discov
. 2024 Dec;
14(12):2346-2351.
PMID: 39618282
No abstract available.
5.
Baker G, Novikov E, Zhao Z, Vallius T, Davis J, Lin J, et al.
Nat Methods
. 2024 Oct;
21(12):2248-2259.
PMID: 39478175
Tumors are complex assemblies of cellular and acellular structures patterned on spatial scales from microns to centimeters. Study of these assemblies has advanced dramatically with the introduction of high-plex spatial...
6.
Timperi E, Croizer H, Khantakova D, Rana M, Molgora M, Guerriero J, et al.
Clin Cancer Res
. 2024 Sep;
30(23):5242-5251.
PMID: 39311702
Tumor-associated macrophages (TAM) constitute a prominent immune cell population within various solid cancers, playing a pivotal role in disease progression. Their increased numbers and frequencies often strongly correlate with resistance...
7.
Kapate N, Dunne M, Gottlieb A, Mukherji M, Suja V, Prakash S, et al.
Adv Healthc Mater
. 2024 Apr;
14(5):e2304144.
PMID: 38581301
Adoptive cell therapies are dramatically altering the treatment landscape of cancer. However, treatment of solid tumors remains a major unmet need, in part due to limited adoptive cell infiltration into...
8.
Goldberg J, Qiao N, Guerriero J, Gross B, Meneksedag Y, Lu Y, et al.
Cancer Res Commun
. 2024 Feb;
4(2):496-504.
PMID: 38335301
Significance: Estrogen receptor (ESR1) mutations have emerged as a key factor in endocrine therapy resistance. We identified and validated five novel, immunogenic ESR1-derived peptides that could be targeted through vaccine-based...
9.
Guerriero J, Lin J, Pastorello R, Du Z, Chen Y, Townsend M, et al.
NPJ Breast Cancer
. 2024 Jan;
10(1):2.
PMID: 38167908
Emerging data suggests that HER2 intratumoral heterogeneity (ITH) is associated with therapy resistance, highlighting the need for new strategies to assess HER2 ITH. A promising approach is leveraging multiplexed tissue...
10.
Patterson-Fortin J, Jadhav H, Pantelidou C, Phan T, Grochala C, Mehta A, et al.
Nat Commun
. 2023 Dec;
14(1):8193.
PMID: 38081854
No abstract available.